Assenagon Asset Management S.A. purchased a new stake in Byline Bancorp, Inc. (NYSE:BY – Get Rating) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 116,966 shares of the company’s stock, valued at approximately $3,199,000. Assenagon Asset Management S.A. owned about 0.31% of Byline Bancorp at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Royal Bank of Canada raised its stake in Byline Bancorp by 66.8% during the third quarter. Royal Bank of Canada now owns 2,915 shares of the company’s stock worth $71,000 after purchasing an additional 1,167 shares during the period. UBS Asset Management Americas Inc. raised its stake in Byline Bancorp by 6.0% during the third quarter. UBS Asset Management Americas Inc. now owns 23,507 shares of the company’s stock worth $577,000 after purchasing an additional 1,337 shares during the period. Citigroup Inc. raised its stake in Byline Bancorp by 89.8% during the third quarter. Citigroup Inc. now owns 3,179 shares of the company’s stock worth $78,000 after purchasing an additional 1,504 shares during the period. Janney Montgomery Scott LLC raised its stake in Byline Bancorp by 11.4% during the fourth quarter. Janney Montgomery Scott LLC now owns 19,162 shares of the company’s stock worth $524,000 after purchasing an additional 1,959 shares during the period. Finally, Credit Suisse AG raised its stake in Byline Bancorp by 12.6% during the third quarter. Credit Suisse AG now owns 19,339 shares of the company’s stock worth $475,000 after purchasing an additional 2,161 shares during the period. Institutional investors and hedge funds own 43.25% of the company’s stock.
In other Byline Bancorp news, EVP Hart Angela E. Major bought 1,000 shares of the business’s stock in a transaction dated Friday, February 25th. The shares were acquired at an average price of $27.30 per share, with a total value of $27,300.00. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider John Barkidjija sold 20,000 shares of the firm’s stock in a transaction on Friday, March 11th. The shares were sold at an average price of $27.38, for a total transaction of $547,600.00. The disclosure for this sale can be found here. Company insiders own 34.96% of the company’s stock.
Byline Bancorp (NYSE:BY – Get Rating) last posted its quarterly earnings results on Thursday, January 27th. The company reported $0.69 earnings per share for the quarter. The company had revenue of $80.74 million for the quarter. Byline Bancorp had a net margin of 28.71% and a return on equity of 12.97%. During the same period in the prior year, the business earned $0.38 EPS. Research analysts forecast that Byline Bancorp, Inc. will post 1.91 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 22nd. Stockholders of record on Tuesday, February 8th were paid a $0.09 dividend. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date was Monday, February 7th. Byline Bancorp’s dividend payout ratio is presently 15.00%.
About Byline Bancorp (Get Rating)
Byline Bancorp, Inc operates as the bank holding company for Byline Bank that provides various banking products and services for small and medium sized businesses, commercial real estate and financial sponsors, and consumers in the United States. It offers various retail deposit products, including non-interest-bearing accounts, money market demand accounts, savings accounts, interest-bearing checking accounts, and time deposits; ATM and debit cards; and online, mobile, and text banking services, as well as commercial deposits.
- Get a free copy of the StockNews.com research report on Byline Bancorp (BY)
- It’s Personal: 3 Personal Care Stocks to Own in Volatile Markets
- Conagra Stock Has More Room to Grow
- 3 Recession-Proof Stocks to Buy Now
- MarketBeat: Week in Review 4/4 – 4/8
- 3 Best Life Sciences Stocks to Buy Now
Receive News & Ratings for Byline Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Byline Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.